Skip to NavigationSkip to content

News

0
As Novartis' once-promising heart failure drug plummets in Phase 3 trials and the FDA approves the first Parkinson's treatment in a decade, check out...
0
Cancer Research UK has revealed a £10 million investment into PRECISION-Panc, a pancreatic cancer-focused project which aims to improve patient...
0
This report provides an analysis of the Australian pharmaceutical and biopharmaceutical industry through the lens of patents. By using the scale and...

Features

Pamela Yeh, UCLA assistant professor of ecology and evolutionary biology, talks to Pharmafocus on her recent work to combat the increasing risk of...